Isolated layer pulse oximetry

• US 5,746,206 A
• Filed: 06/10/1996
• Issued: 05/05/1998
• Est. Priority Date: 03/14/1995
• Status: Expired due to Term

• Current Assignee: Nellcor Incorporated (Medtronic Plc)
• Original Assignee: Nellcor Incorporated (Medtronic Plc)
• Inventors: Mannheimer, Paul D.
• Primary Examiner(s): Bahr, Jennifer
• Assistant Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US08/662,439
• Time in Patent Office: 694 Days
• Field of Search: 128/633, 128/664, 128/665, 356/41
• US Class Current: 600/336
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/14552 Details of sensors specially adapted therefor
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/49 within a body or fluid

Abstract

An apparatus of and method for measuring arterial blood oxygen saturation at a particular tissue level of interest. Visible and near infrared radiation is emitted into a patient at the measurement site using two different wavelengths. Detection at two different detection sites permits rejection of oxygen saturation at undesired tissue levels.

Claims

1. An apparatus comprising:

a. a patient interface adapted to be coupled to a patient;

b. an emitter of electromagnetic radiation coupled to said patient interface;

c. a first detector coupled to said patient interface at a first distance from said emitter;

d. a second detector coupled to said patient interface at a second distance from said emitter;

e. means for synchronizing an oxygen saturation measurement to a predetermined portion of a cardiac cycle of said patient; and

f. means coupled to said first and said second detectors and said synchronizer for computing an oxygen saturation level of arterial blood of said patient, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.

2. An apparatus according to claim 1 wherein said emitter emits a plurality of predetermined wavelengths of electromagnetic radiation.

3. An apparatus according to claim 2 wherein said emitter emits two predetermined wavelengths of electromagnetic radiation.

4. A pulse oximeter apparatus for calculating arterial oxygen saturation, comprising:

a. a patient interface adapted to be coupled to a patient and including at least three sensor areas for emitting electromagnetic radiation which penetrates tissue of the patient and detects that electromagnetic radiation scattered by the tissue, a first spacing being between a first combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector a second spacing being between a second combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector, the first spacing being different from the second spacing; and

b. means for calculating an arterial oxygen saturation level of the patient in response to the detected electromagnetic radiation, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.

5. A method of measuring oxygen saturation level of arterial blood at a measurement site of a patient comprising:

a. determining a time of arrival of an arterial pulse wavefront at the measurement site of the patient;

b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient;

c. measuring an amplitude of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site;

d. measuring an amplitude of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site;

e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient;

f. measuring an amplitude of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site;

g. measuring an amplitude of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site;

h. computing an arterial oxygen saturation level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the amplitudes of the first wavelength measured at the first detector and the second detector, using the amplitudes of the second wavelength measured at the first detector and the second detector, and rejecting oxygen saturation level of venous blood of the patient.

6. A method of measuring a blood characteristic at a measurement site of a patient comprising:

a. determining a time of arrival of an arterial pulse wavefront at the measuring site of the patient;

b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient;

c. measuring an intensity of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site;

d. measuring an intensity of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site;

e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient;

f. measuring an intensity of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site;

g. measuring an intensity of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site;

h. determining a blood characteristic level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the intensities of the first wavelength measured at the first detector and the second detector, using the intensities of the second wavelength measured at the first detector and the second detector, and rejecting blood characteristic level of venous blood of the patient.